CA$
4. 4000
-0.04
-0.9%
CA$
145.11M Market Cap
- P/E Ratio
0.2% Div Yield
311 Volume
0 Eps
CA$ 4.44
Previous Close Want to track HLS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
HLS Therapeutics Inc. (HLS) Statistics
Valuation metrics
Market Cap 145.11M
Enterprise value 244.22M
Trailing P/E (ttm) -11.9
Forward P/E -111.83
PEG ratio 0.24
Price/Sales (ttm) 2.6
Price/Book (mrq) 1.89
Enterprise Value/Revenue 3.17
Enterprise Value/EBITDA 10.19
Overview
Shares outstanding 31.27M
Float 19.62M
Shares short 7.05K
% Held by insiders 0.01%
% Held by institutions 0.43%
Average volume (10 days) 5.29K
Average volume (90 days) 6.83K
Price summary
52-Week low 4.22
52-Week high 5.76
Beta 0.83
50-Day moving average 4.53
200-Day moving average 4.92
Dividends and splits
Forward annual dividend rate 0.2
Forward annual dividend yield 0.0431%
Trailing annual dividend rate 0.2
Trailing annual dividend yield 0.0431%
5-Year annual dividend yield 1.73%
Payout ratio -
Dividend Date 15 Jun 2023
Ex-Dividend Date 27 Apr 2023
Last split factor 1:5
Last split Date 26 Oct 2006
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.18%
Operating margin -0.17%
Operational effectiveness
Return on assets -0.02%
Return on equity -0.16%
Income Statement
Revenue (ttm) 77.03M
Revenue per share (ttm) 1.77
Quarterly revenue growth (yoy) 0.02%
Gross profit (ttm) 54.72M
EBITDA 18.16M
Net income to common (ttm) -14.22M
Diluted EPS (ttm) -0.44
Quarterly earnings growth (yoy) 0.02%
Balance Sheet
Total cash (mrq) 17.03M
Total cash per share (mrq) 0.39
Total debt (mrq) 60.71M
Total Debt/Equity (mrq) 75
Current ratio (mrq) 1%
Book value per share (mrq) 2.45
Cash Flow
Cash flow statement 27.58M
Levered free cash flow (LFCF) 28.67M
